Biosimilars Forum Welcomes PBM Transparency Act

US Proposals Would See Spread Pricing Outlawed And Rebates Disclosed

 
• By Chloe Kent
  
Man writing the word transparency
The proposals would require significantly increased transparency from PBMs. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Policy & Regulation

More from Generics Bulletin